What does it mean to have abnormal lab results and what are the next steps for evaluation and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpreting Abnormal Lab Results: A Systematic Approach

Do not simply repeat abnormal laboratory tests hoping they will normalize—immediately investigate the underlying cause unless you have high clinical certainty the abnormality is transient. 1

Why Routine Repeat Testing is Ineffective

The evidence strongly argues against the common practice of "wait and repeat":

  • 84% of abnormal liver tests remain abnormal at 1 month, and 75% remain abnormal at 2 years, making routine repeat testing an inefficient strategy that only delays diagnosis of treatable conditions 1
  • The most frequent cause of an abnormal test result is physiologic variation or laboratory variation, but this does not mean the result should be ignored 2, 3
  • Repeating tests is only justified when you have high clinical certainty the abnormality will resolve in response to an identified acute insult (e.g., recent viral illness, muscle injury, or short-term medication exposure) 1

Confirming True Abnormalities

Before pursuing extensive workup, verify the abnormality is real:

  • In the absence of unequivocal clinical findings, diagnosis of any condition requires two abnormal test results from the same sample or in two separate test samples 4
  • If using two separate test samples, the second test should be performed without delay 4
  • All tests have preanalytic and analytic variability—samples for plasma glucose must be spun and separated immediately after they are drawn to avoid spurious results 4
  • Marked discrepancies between different test results should prompt consideration of assay interference or preanalytical errors 4, 5

Initial Diagnostic Approach Based on Test Type

For Abnormal Glucose/Diabetes Testing

  • If A1C is 7.0% and repeat is 6.8%, diabetes is confirmed 4
  • If two different tests (A1C and fasting plasma glucose) are both above diagnostic threshold, diagnosis is confirmed 4
  • With discordant results from two different tests, repeat the test that is above the diagnostic cut point 4
  • For patients with test results near diagnostic margins, repeat testing in 3-6 months is reasonable 4
  • A1C is unreliable in conditions with increased red blood cell turnover (sickle cell disease, pregnancy second/third trimesters, G6PD deficiency, hemodialysis, recent blood loss/transfusion, erythropoietin therapy)—use only plasma glucose criteria in these patients 4

For Abnormal Liver Tests

Perform a comprehensive etiologic workup immediately rather than repeating tests 1:

  • Core laboratory panel: complete blood count, comprehensive metabolic panel, hepatitis B surface antigen, hepatitis C antibody, anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins, simultaneous serum ferritin and transferrin saturation 4, 1
  • Abdominal ultrasound is mandatory first-line imaging (98% positive predictive value for cirrhosis, 71-97% specificity for excluding biliary obstruction) 4, 6, 1
  • If ALT >1000 U/L, add hepatitis A, E, and cytomegalovirus serologies 1
  • The extent of liver blood test abnormality is not necessarily a guide to clinical significance—mild elevations can represent serious progressive disease 4, 1

For Bilirubinuria (Bilirubin in Urine)

The presence of bilirubin in urine indicates conjugated hyperbilirubinemia requiring prompt diagnostic evaluation 6:

  • Verify conjugated bilirubin represents >35% of total bilirubin 6
  • Ultrasound abdomen is first-line imaging with 98% positive predictive value and 65-95% sensitivity for liver parenchymal disease 6
  • Consider viral hepatitis serologies, autoimmune markers, and drug toxicity evaluation 6
  • Do not simply repeat urinalysis or wait to see if bilirubinuria resolves—most abnormalities represent true pathology requiring diagnosis 6

Critical Pitfalls to Avoid

  • Don't assume mild elevations are insignificant—conditions like NAFLD, hepatitis C, and alcohol-related liver disease often present with only mild abnormalities but can progress to cirrhosis 1
  • Don't stop investigating if tests normalize—normal liver tests do not exclude chronic liver disease 1
  • Absence of symptoms does not mean benign disease—many patients with significant liver fibrosis remain asymptomatic until advanced disease develops 6
  • Pre-analytical errors (improper sample collection, handling, or transport) are the most common source of laboratory mistakes (46-68.2% of total errors) 7
  • False-positive laboratory results are 8 times more frequent than true positives in patients undergoing routine testing 4

When to Refer Urgently

Immediate specialist referral is indicated for 6, 1:

  • Clinical jaundice
  • Suspicion of hepatobiliary malignancy
  • Markedly elevated transaminases (>1000 U/L)
  • Evidence of hepatic decompensation
  • Positive hepatitis B or C serology
  • Abnormal liver tests with negative extended workup and no NAFLD risk factors
  • Evidence of advanced liver disease or cirrhosis

Special Populations

In children, the differential diagnosis is broader and alpha-1-antitrypsin level, caeruloplasmin (age >3 years), and anti-liver kidney microsomal antibody should be included in the workup 4, 1

In neonates and infants, conjugated bilirubin >25 μmol/L requires urgent pediatric assessment for possible liver disease 6

References

Guideline

Abnormal Liver Test Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of laboratory tests used in screening ambulatory patients.

Clinical obstetrics and gynecology, 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bilirubin in Urine: Clinical Significance and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Errors in clinical laboratories or errors in laboratory medicine?

Clinical chemistry and laboratory medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.